An observational study in Venous Thromboembolism, sponsored by China-Japan Friendship Hospital. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2020-12-11.
Sponsored by China-Japan Friendship Hospital · Observational
The investigators aimed to test the reliability and validity of the Chinese version of patient-completed CRS in hospitalized patients and to evaluate whether this form can be widely used in clinical practice instead of only health care workers' evaluation.
818 studies on the registry are indexed under Thromboembolism; 98 are open to participants now.
This study's planned enrollment of 1,017 is above the median of 500 across 344 observational studies indexed under Thromboembolism.
Browse Thromboembolism studies →China-Japan Friendship Hospital is the lead sponsor of 173 studies on the registry; 109 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The investigators will recruite nearly 500 inpatients from the surgical unit and nearly 500 inpatients from the medical unit between January 1 and December 31, 2019
Exclusion Criteria:
Diagnostic Test: patient-completed Caprini Risk Score
Diagnostic Test: patient-completed Caprini Risk Score
The participants will be asked to complete patient-completed Caprini Risk Score
Question-to-question agreement between patient-completed and nurse-completed CRS
The investigators will use kappa value to compare the question-to-question agreement level between nurse and patient-completed Caprini Risk Score
Time frame: one year
Correlation and difference between the scores calculated by patient-completed and nurse-completed CRS
The Spearman correlation coefficient was used to measure the correlation and difference between patient-completed and nurse-completed CRS.
Time frame: one year
This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China-Japan Friendship Hospital